Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Lafitte

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
BMC Cancer|July 4, 2001
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisA P Meert, M Paesmans, T Berghmans, et al.
British Journal of Cancer|September 11, 2003
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literatureA-P Meert, B Martin, M Paesmans, et al.
Bulletin Du Cancer|January 1, 1990
Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patientsJ M Tourani, D Penaud, I Caubarrere, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2002
Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysisT Berghmans, M Paesmans, J J Lafitte, et al.
The European Respiratory Journal|November 22, 2001
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysisE Steels, M Paesmans, T Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2005
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesotheliomaT Berghmans, J J Lafitte, M Paesmans, et al.
Revue De Pneumologie Clinique|February 5, 2013
[Castleman's disease: unusual presentation of Castleman's disease and review of literature]A Baranzelli, R Akkad, B Bouchindhomme, et al.
Revue Medicale De Bruxelles|January 29, 2002
[The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers]J P Sculier, T Berghmans, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapyJ P Sculier, T Berghmans, J J Lafitte, et al.
British Journal of Cancer|June 21, 2006
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsC Mascaux, B Martin, M Paesmans, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
BMC Cancer|July 4, 2001
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisA P Meert, M Paesmans, T Berghmans, et al.
British Journal of Cancer|September 11, 2003
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literatureA-P Meert, B Martin, M Paesmans, et al.
Bulletin Du Cancer|January 1, 1990
Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patientsJ M Tourani, D Penaud, I Caubarrere, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2002
Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysisT Berghmans, M Paesmans, J J Lafitte, et al.
The European Respiratory Journal|November 22, 2001
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysisE Steels, M Paesmans, T Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2005
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesotheliomaT Berghmans, J J Lafitte, M Paesmans, et al.
Revue De Pneumologie Clinique|February 5, 2013
[Castleman's disease: unusual presentation of Castleman's disease and review of literature]A Baranzelli, R Akkad, B Bouchindhomme, et al.
Revue Medicale De Bruxelles|January 29, 2002
[The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers]J P Sculier, T Berghmans, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapyJ P Sculier, T Berghmans, J J Lafitte, et al.
British Journal of Cancer|June 21, 2006
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsC Mascaux, B Martin, M Paesmans, et al.
Pageof 16